Effectiveness of switching from protease inhibitors to dolutegravir in combination with nucleoside reverse transcriptase inhibitors as maintenance antiretroviral therapy among HIV-positive patients

Pharmacogenomics and Antiretroviral Therapy: Pharmacogenomics of HIV-1 Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors - Implications for Personalized Antiretroviral Therapy

Frontiers in HIV Research ◽

10.2174/9781681080567115010010 ◽

2015 ◽

pp. 97-114

Keyword(s):

Antiretroviral Therapy ◽

Reverse Transcriptase ◽

Protease Inhibitors ◽

Hiv 1

Guide to Major Clinical Trials of Antiretroviral Therapy in Human Immunodeficiency Virus‐Infected Patients: Protease Inhibitors, Non‐Nucleoside Reverse Transcriptase Inhibitors, and Nucleotide Reverse Transcriptase Inhibitors

Clinical Infectious Diseases ◽

10.1086/515179 ◽

1999 ◽

Vol 28 (3) ◽

pp. 643-676 ◽

Cited By ~ 29

Author(s):

Jorge A. Tavel ◽

Kirk D. Miller ◽

Henry Masur

Keyword(s):

Human Immunodeficiency Virus ◽

Clinical Trials ◽

Antiretroviral Therapy ◽

Reverse Transcriptase ◽

Protease Inhibitors ◽

Immunodeficiency Virus

Factors Related to Virologic Failure among HIV-Positive Injecting Drug Users Treated with Combination Antiretroviral Therapy Including Two Nucleoside Reverse Transcriptase Inhibitors and Nevirapine

AIDS Patient Care and STDs ◽

10.1089/10872910252806117 ◽

2002 ◽

Vol 16 (2) ◽

pp. 67-73 ◽

Cited By ~ 25

Author(s):

M. Zaccarelli ◽

A. Barracchini ◽

P. De Longis ◽

C.F. Perno ◽

F. Soldani ◽

...

Keyword(s):

Antiretroviral Therapy ◽

Reverse Transcriptase ◽

Drug Users ◽

Virologic Failure ◽

Injecting Drug Users ◽

Hiv Positive ◽

Combination Antiretroviral Therapy ◽

Superiority of Protease Inhibitors over Nonnucleoside Reverse-Transcriptase Inhibitors when Highly Active Antiretroviral Therapy Is Resumed after Treatment Interruption

Clinical Infectious Diseases ◽

10.1086/432887 ◽

2005 ◽

Vol 41 (6) ◽

pp. 897-900 ◽

Cited By ~ 8

Author(s):

P. Barreiro ◽

C. de Mendoza ◽

J. Gonzalez-Lahoz ◽

V. Soriano

Keyword(s):

Antiretroviral Therapy ◽

Reverse Transcriptase ◽

Protease Inhibitors ◽

Highly Active Antiretroviral Therapy ◽

Treatment Interruption ◽

Nonnucleoside Reverse Transcriptase Inhibitors ◽

Highly Active

Ultra-performance liquid chromatographic method for simultaneous quantification of HIV non-nucleoside reverse transcriptase inhibitors and protease inhibitors in human plasma

Journal of the Brazilian Chemical Society ◽

10.1590/s0103-50532011000100018 ◽

2011 ◽

Vol 22 (1) ◽

pp. 134-141 ◽

Cited By ~ 7

Author(s):

Marina V. Antunes ◽

Júlia Poeta ◽

Jorge P. Ribeiro ◽

Eduardo Sprinz ◽

Rafael Linden

Keyword(s):

Reverse Transcriptase ◽

Human Plasma ◽

Protease Inhibitors ◽

Chromatographic Method ◽

Simultaneous Quantification ◽

Liquid Chromatographic Method ◽

Liquid Chromatographic

Protease inhibitors/nucleoside reverse transcriptase inhibitors

Reactions Weekly ◽

10.1007/s40278-020-73423-6 ◽

2020 ◽

Vol 1785 (1) ◽

pp. 442-442

Keyword(s):

Reverse Transcriptase ◽

Protease Inhibitors ◽

A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial

The Lancet ◽

10.1016/s0140-6736(06)69861-9 ◽

2006 ◽

Vol 368 (9553) ◽

pp. 2125-2135 ◽

Cited By ~ 100

Author(s):

Rodger D MacArthur ◽

Richard M Novak ◽

Grace Peng ◽

Li Chen ◽

Ying Xiang ◽

...

Keyword(s):

Reverse Transcriptase ◽

Protease Inhibitors ◽

Antiretroviral Treatment ◽

Randomised Trial ◽

Treatment Strategies ◽

Initial Therapy ◽

Highly Active

Viro-immunological efficacy and tolerability of dolutegravir-based regimens compared to regimens based on other integrase strand inhibitors, protease inhibitors or non-nucleoside reverse transcriptase inhibitors in patients with acute HIV-1 infection: A multicenter retrospective cohort study

International Journal of Antimicrobial Agents ◽

10.1016/j.ijantimicag.2019.06.003 ◽

2019 ◽

Vol 54 (4) ◽

pp. 487-490 ◽

Cited By ~ 3

Author(s):

F. Lagi ◽

G. Baldin ◽

M. Colafigli ◽

A. Capetti ◽

G. Madeddu ◽

...

Keyword(s):

Cohort Study ◽

Reverse Transcriptase ◽

Protease Inhibitors ◽

Retrospective Cohort Study ◽

Retrospective Cohort ◽

Acute Hiv ◽

Hiv 1

Non-nucleoside reverse transcriptase inhibitors emerging as an attractive alternative to protease inhibitors in HIV combination therapy regimens

Drugs & Therapy Perspectives ◽

10.2165/00042310-200117190-00002 ◽

2001 ◽

Vol 17 (19) ◽

pp. 4-7

Author(s):

&NA;

Keyword(s):

Combination Therapy ◽

Reverse Transcriptase ◽

Protease Inhibitors ◽

Attractive Alternative ◽

Induction with Lopinavir-Based Treatment Followed by Switch to Nevirapine-Based Regimen versus Non-Nucleoside Reverse Transcriptase Inhibitors-Based Treatment for First Line Antiretroviral Therapy in HIV Infected Children Three Years and Older

PLoS ONE ◽

10.1371/journal.pone.0108063 ◽

2014 ◽

Vol 9 (9) ◽

pp. e108063 ◽

Cited By ~ 1

Author(s):

Gerardo Alvarez-Uria ◽

Raghavakalyan Pakam ◽

Praveen Kumar Naik ◽

Manoranjan Midde

Keyword(s):

Antiretroviral Therapy ◽

Reverse Transcriptase ◽

First Line ◽